Insulet (NSDQ:PODD) announced that Elizabeth (Bess) Weatherman was appointed to its board of directors.
Weatherman — a veteran dealmaker in the health technology space — will stand for election by stockholders at the company’s 2022 annual meeting and has been named to the board’s Compensation Committee.
Acton, Massachusetts–based Insulet said in a news release that Weatherman currently serves as a special limited partner of Warburg Pincus LLC, having originally joined in 1988 with a primary focus on investment activities in the healthcare sector. She led the firm’s healthcare group from 2008 to 2015.
Weatherman has twice been named to the Forbes Midas List in recognition of her position as one of the 100 most highly regarded dealmakers in the venture capital industry, while she also received the 2014 Women of Power and Influence Award from the National Organization of Women. She currently serves as a director of Nevro, Silk Road Medical and Vapotherm.
“On behalf of the board, I am excited to welcome Bess to Insulet,” Timothy Scannell, chairman of Insulet’s board of directors, said in the release. “Bess brings extensive experience in healthcare and is highly regarded in the medical technology and private equity industries. Her strong leadership and strategic and governance perspectives will add tremendous value as we continue to advance our growth initiatives.”
The company also announced that, following six years of service to the Insulet board of directors, board member David Lemoine will retire in May.
“We thank Dave for his leadership and significant contributions to Insulet,” Scannell said. “Dave has been a steadfast partner to the board, and we wish him well in his retirement.”
